XPO1 and acute myeloid leukemia: In addition, we have quantitatively assessed the CRM1HA interaction with the NESs of different AML-associated mutants using both a fluorescence-based binding assay and isothermal titration calorimetry (ITC), in an attempt to rationalize their export behavior in terms of CRM1 binding properties.